Case Report
Accepted on 27 Feb 2026
Long complete metabolic response assessed by LAFOV FDG-PET/CT to FOLFIRINOX in first-line treatment of metastatic low-differentiated pancreatic carcinoma.
in Medical Imaging and Nuclear Medicine
Case Report
Accepted on 27 Feb 2026
in Medical Imaging and Nuclear Medicine
Case Report
Accepted on 27 Feb 2026
in Hematologic Malignancies
Systematic Review
Accepted on 27 Feb 2026
in Exercise Physiology
Original Research
Accepted on 27 Feb 2026
Original Research
Accepted on 27 Feb 2026
in Insect Systematics
Original Research
Accepted on 27 Feb 2026
in Sustainable and Intelligent Phytoprotection
Original Research
Accepted on 27 Feb 2026
in Movement Disorders
Review
Accepted on 27 Feb 2026
in Multifaceted Approaches in Cancer Support
Original Research
Accepted on 27 Feb 2026
in Plant Metabolism and Chemodiversity
Editorial
Accepted on 27 Feb 2026
in Molecular Signalling and Pathways
Editorial
Accepted on 27 Feb 2026
in Cognitive Neuroergonomics
Hypothesis and Theory
Accepted on 27 Feb 2026
in Learning and Memory
Original Research
Accepted on 27 Feb 2026
in Motor Neuroscience
Original Research
Accepted on 27 Feb 2026
in Exercise Physiology
Original Research
Accepted on 27 Feb 2026
in Brain Imaging and Stimulation
Original Research
Accepted on 27 Feb 2026
in Veterinary Pharmacology and Toxicology